Sentences with phrase «with pharmaceutical compounds»

It has also been discovered in the same research that more potent drugs, with pharmaceutical compounds not unlike resveratrol, may have the potential for preventing and treating age related diseases and illnesses.

One result of the team's painstaking research was the discovery of how a specific protein influences neutrophil activation — and, more importantly, the team showed they were able to block damaging inflammation by over-compensating neutrophils with a pharmaceutical compound.

Not exact matches

The global market for pharmaceutical contract manufacturing, contract research and contract packaging will grow from $ 136.4 billion in 2017 to $ 197.0 billion by 2022 with a compound annual growth rate (CAGR) of 7.6 % for the period of 2017 - 2022.

A 2013 joint report from epilepsy research organizations explained that «because the marketplace is already awash with [antiseizure drugs], many pharmaceutical companies now refrain from the expensive enterprise of developing new compounds.»

The novel technique may be useful for making compounds important in agriculture and pharmaceuticals with less damage to the environment.

But this also provides ample time for chlorine to interact with pharmaceuticals that may be in the water, encouraging development of new antibiotic compounds.

Yu is now collaborating with the pharmaceutical company Bristol - Myers Squibb to use his meta - C - H activation techniques to make potential new drug compounds.

For example, the best national pharmaceutical companies are starting to invest in the validation of plant - derived medicines in an attempt to lay claim to new medicines and compete with the conventional imported compounds, which make up over 70 % of the Brazilian market.

He also plans to reach out to and collaborate with biologists and medical researchers to develop active agents for pharmaceuticals to treat cancers or inflammatory diseases from these beer - inspired compounds.

PsychoGenics leverages its sophisticated Cube technology platforms and broad capabilities to partner with pharmaceutical, biotechnology and not - for - profit research entities to screen diverse compound libraries and discover valuable new therapies for the CNS market.

We established formal partnerships with major pharmaceutical and biotechnology companies to develop compounds or identify targets that enhance interneuron function or restore brain rhythms in models of AD and epilepsy.

These risks and uncertainties include, among others, those relating to our ability to obtain financing and to form collaborative relationships, uncertainty regarding potential future deterioration in the market for auction rate securities which could result in additional permanent impairment charges, our ability to develop and market diagnostic products, the level of third party reimbursement for our products, risks related to preclinical and clinical development of pharmaceutical products, including the identification of compounds and the completion of clinical trials, the effect of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission, including, without limitation, the risk factors identified in our most recent Annual Report on Form 10 - K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on Form 8 - K.

He and his team, in collaboration with pharmaceutical company AstraZeneca, are currently using the new peptides to discover Gαq - blocking compounds that might be developed into treatments for this form of cancer.

In recent years, the lab has actively collaborated with pharmaceutical companies to obtain compounds in early stages of preclinical and clinical development.

These risks and uncertainties include, among others, those relating to our ability to obtain sufficient financing to continue as a going concern, our ability to develop and market diagnostic products, the level of third party reimbursement for our products, risks related to preclinical and clinical development of pharmaceutical products, including the identification of compounds and the completion of clinical trials, our ability to form collaborative relationships, the effect of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission, including, without limitation, the risk factors identified in our most recent Annual Report on Form 10 - K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on Form 8 - K.

Currently, the Herlyn Laboratory collaborates with pharmaceutical companies as well as academic chemists and structural biologists to select and further develop compounds for tumor inhibition.

A collaboration with the Roche pharmaceutical company led to the screening of 200 000 Roche compounds on human neural stem cells in order to identify proliferative drugs.

However, with few exceptions, the stem cell and regenerative medicine industry has remained inadequately capitalized to carry out large - scale clinical trials independently, and major pharmaceutical firms have tended to show more interest in the use of hiPSCs as a source of large, pure populations of specific somatic cells for use in drug compound screening and toxicology tests, than they have in therapeutic uses of stem cells and their derivatives.

These risks and uncertainties include, among others, those relating to our ability to obtain sufficient financing to continue as a going concern, the outcome of the review of the continued listing of our common stock on The Nasdaq Stock Market, our ability to develop and market diagnostic products, the level of third party reimbursement for our products, risks related to preclinical and clinical development of pharmaceutical products, including the identification of compounds and the completion of clinical trials, our ability to form collaborative relationships, the effect of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission, including, without limitation, the risk factors identified in our most recent Annual Report on Form 10 - K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on Form 8 - K.

Ultimately, two of the identified genes led to compounds being studied in drug development projects with pharmaceutical partners.

«It's one thing to only try to correct splicing events, but there are a lot more opportunities in terms of drug targets,» says Gideon Dreyfuss, a biochemist at the University of Pennsylvania Perelman School of Medicine in Philadelphia who is working with the New Jersey — based pharmaceutical firm Merck to discover new compounds.

Compounded medications will have slightly more variance than standard pharmaceuticals, but it sounds like that was not the issue with your most recent case.

Anti-doping rules cloud the issues of what is «natural» and what isn't, pharmaceutical - type labeling on herbal remedies and wild claims regarding performance enhancement or fat loss (rightly) turn most consumers into skeptics, and massive price tags on tubs of sugar with trace amounts of «popular» compounds give a warped sense of the cost of high performance.

A recent study showed that a new drug — developed by GW Pharmaceuticals and made from cannabidiol, which is one of the main compounds found in cannabis — was able to significantly reduce seizures in patients with Lennox - Gastaut syndrome.

Maintains records associated with departmental functions assigned to the technician, i.e. times of making pharmacy rounds, times of sending medications via the pneumatic tube system, refrigerator temperatures, crash cart fills, documentation of compounding and pre-packing pharmaceutical products, etc..

Pharmacy Technicians deals with many responsibilities and duties such as count tables, compound, pack and label pharmaceutical products, choose the correct prescription container and level it, work on joint project with pharmacy technicians of other pharmacy companies, and calculate the price of the prescription.

Familiar with medication compounding and pharmaceutical calculations, experience acquired in my externship at Walgreens

Accurately recorded compounded products and prepared appropriate labels.Retrieved, counted and measured drugs and capped and uncapped vials and bottles.Labeled all products appropriately, including cautionary and auxiliary labels.Processed up to 100 prescriptions on high volume days with 100 % accuracy.Mixed various pharmaceutical preparations according to written prescriptions.Calculated, weighed, measured and mixed ingredients with expert precision.Consistently upheld proper pharmacy and general safety procedures and standards.Consistently upheld proper pharmacy and general safety procedures and standards.